Mission
THE NATIONAL SCLERODERMA FOUNDATION'S MISSION IS TO ADVANCE MEDICAL RESEARCH, PROMOTE DISEASE AWARENESS, AND PROVIDE SUPPORT AND EDUCATION TO PEOPLE WITH SCLERODERMA, THEIR FAMILIES AND SUPPORT NETWORKS.
Public Charity
NATIONAL SCLERODERMA FOUNDATION INC
NATIONAL SCLERODERMA FOUNDATION INC, of DANVERS, MA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $6.6M in revenue, $6.8M in expenses, $11.3M in total assets. 90 publicly reported grants to this organization, totaling roughly $3.5M, appear in IRS filings.
EIN: 521375827
DANVERS, MA
Diseases of Specific Organs Research
NTEE: H40
Latest filing: 2025
Total Revenue$6.6M
Total Expenses$6.8M
Total Assets$11.3M
Grant Records90
Funding Total$3.5M
Filing Years2020–2025
Where $100 goes at National Scleroderma Foundation Inc
How National Scleroderma Foundation Inc divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.
$75
Programs
the work itself
$16
Management
running the organization
$9
Fundraising
raising the next dollar
Inside the $75 for programs
$48
A relentless force in finding a cure and improving the lives of people affected by scleroderma, the National Scleroderma Foundation advances medical research, promotes disease awareness, and provides…
$27
Research
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL SUPPORT
$10,906
General Operating Support
$1,500
For grant recipient's exempt purposes
$43,897
GENERAL SUPPORT
$37,630
GENERAL SUPPORT
$37,630
Showing up to 5 of 90 total records — full history available with membership.
Officers & Directors
DIRECTOR
Aj Nahmad
VP OF COMMUNITY ENGAGEMENT
Ashley M Pruett
TREASURER
Blake Embree
VICE CHAIR
Carol Feghali-Bostwick Ph D
SENIOR DIRECTOR, MISSION DELIVERY
Catherine M Anastasia
DIRECTOR
Christina Loccke
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $6.6M | $6.8M | $11.3M |
| 2024 | $4.9M | $7.0M | $11.2M |
| 2023 | $6.9M | $6.5M | $12.9M |
| 2021 | $4.2M | $4.5M | $13.5M |
| 2020 | $3.8M | $5.0M | $11.6M |
Between 2020 and 2025, reported annual revenue grew from $3.8M to $6.6M (+74%), with total assets most recently reported at $11.3M.
Interactive year-over-year charts and full filing details available with membership.